The Cleveland Clinic researchers who drew attention to the heart risks of Vioxx in 2001 are shining the spotlight on another drug: Pargluva, an experimental diabetes pill developed by Bristol-Myers Squibb and Merck .

FORBES: Bristol, Merck Drug May Double Heart Risk